日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/01/21 | 3,704 | 3,754 | 3,701 | 3,748 | +11 | +0.3% | 157,700 |
| 2025/01/20 | 3,701 | 3,771 | 3,700 | 3,737 | +30 | +0.8% | 211,600 |
| 2025/01/17 | 3,800 | 3,816 | 3,706 | 3,707 | -113 | -3% | 197,100 |
| 2025/01/16 | 3,834 | 3,864 | 3,820 | 3,820 | +1 | ±0% | 168,600 |
| 2025/01/15 | 3,850 | 3,888 | 3,780 | 3,819 | -58 | -1.5% | 241,300 |
| 2025/01/14 | 3,930 | 3,968 | 3,866 | 3,877 | -81 | -2% | 283,200 |
| 2025/01/10 | 3,980 | 3,994 | 3,941 | 3,958 | -41 | -1% | 188,800 |
| 2025/01/09 | 4,018 | 4,051 | 3,945 | 3,999 | -11 | -0.3% | 223,300 |
| 2025/01/08 | 4,047 | 4,074 | 4,010 | 4,010 | -42 | -1% | 198,400 |
| 2025/01/07 | 4,055 | 4,095 | 4,028 | 4,052 | +16 | +0.4% | 363,200 |
| 2025/01/06 | 3,997 | 4,088 | 3,961 | 4,036 | +47 | +1.2% | 293,900 |
| 2024/12/30 | 3,987 | 4,006 | 3,963 | 3,989 | -18 | -0.4% | 187,800 |
| 2024/12/27 | 3,970 | 4,015 | 3,960 | 4,007 | +76 | +1.9% | 287,600 |
| 2024/12/26 | 3,962 | 3,979 | 3,923 | 3,931 | -57 | -1.4% | 322,500 |
| 2024/12/25 | 4,010 | 4,038 | 3,932 | 3,988 | +6 | +0.2% | 214,300 |
| 2024/12/24 | 3,862 | 4,015 | 3,846 | 3,982 | +133 | +3.5% | 524,600 |
| 2024/12/23 | 4,043 | 4,098 | 3,745 | 3,849 | -334 | -8% | 1,249,100 |
| 2024/12/20 | 4,200 | 4,222 | 4,174 | 4,183 | +26 | +0.6% | 399,000 |
| 2024/12/19 | 4,135 | 4,191 | 4,133 | 4,157 | -32 | -0.8% | 324,800 |
| 2024/12/18 | 4,219 | 4,252 | 4,180 | 4,189 | -2 | ±0% | 290,900 |
| 2024/12/17 | 4,237 | 4,258 | 4,155 | 4,191 | +6 | +0.1% | 314,900 |
| 2024/12/16 | 4,168 | 4,208 | 4,123 | 4,185 | +49 | +1.2% | 289,800 |
| 2024/12/13 | 4,152 | 4,200 | 4,136 | 4,136 | -38 | -0.9% | 271,600 |
| 2024/12/12 | 4,195 | 4,225 | 4,172 | 4,174 | +1 | ±0% | 236,600 |
| 2024/12/11 | 4,210 | 4,229 | 4,141 | 4,173 | -51 | -1.2% | 209,100 |
| 2024/12/10 | 4,258 | 4,271 | 4,191 | 4,224 | -1 | ±0% | 263,100 |
| 2024/12/09 | 4,264 | 4,271 | 4,210 | 4,225 | -19 | -0.4% | 295,100 |
| 2024/12/06 | 4,260 | 4,265 | 4,203 | 4,244 | -16 | -0.4% | 244,700 |
| 2024/12/05 | 4,280 | 4,280 | 4,220 | 4,260 | -6 | -0.1% | 226,500 |
| 2024/12/04 | 4,274 | 4,325 | 4,232 | 4,266 | -67 | -1.5% | 337,600 |
| 2024/12/03 | 4,328 | 4,393 | 4,305 | 4,333 | -12 | -0.3% | 280,600 |
| 2024/12/02 | 4,253 | 4,356 | 4,250 | 4,345 | -13 | -0.3% | 369,900 |
| 2024/11/29 | 4,344 | 4,375 | 4,283 | 4,358 | -30 | -0.7% | 353,900 |
| 2024/11/28 | 4,305 | 4,414 | 4,277 | 4,388 | +116 | +2.7% | 442,300 |
| 2024/11/27 | 4,261 | 4,310 | 4,254 | 4,272 | +4 | +0.1% | 383,900 |
| 2024/11/26 | 4,182 | 4,325 | 4,149 | 4,268 | +155 | +3.8% | 711,500 |
| 2024/11/25 | 4,235 | 4,245 | 4,110 | 4,113 | -73 | -1.7% | 452,900 |
| 2024/11/22 | 4,190 | 4,234 | 4,162 | 4,186 | +32 | +0.8% | 434,300 |
| 2024/11/21 | 4,100 | 4,196 | 4,057 | 4,154 | +136 | +3.4% | 387,900 |
| 2024/11/20 | 4,036 | 4,061 | 3,956 | 4,018 | -28 | -0.7% | 283,000 |
| 2024/11/19 | 4,069 | 4,073 | 3,959 | 4,046 | -23 | -0.6% | 455,700 |
| 2024/11/18 | 3,971 | 4,069 | 3,952 | 4,069 | +56 | +1.4% | 339,600 |
| 2024/11/15 | 4,039 | 4,050 | 3,937 | 4,013 | -50 | -1.2% | 277,700 |
| 2024/11/14 | 3,996 | 4,102 | 3,937 | 4,063 | +77 | +1.9% | 562,600 |
| 2024/11/13 | 3,984 | 4,009 | 3,929 | 3,986 | -31 | -0.8% | 458,700 |
| 2024/11/12 | 4,002 | 4,106 | 3,998 | 4,017 | +46 | +1.2% | 371,700 |
| 2024/11/11 | 4,070 | 4,082 | 3,971 | 3,971 | -127 | -3.1% | 228,700 |
| 2024/11/08 | 4,160 | 4,183 | 4,097 | 4,098 | -49 | -1.2% | 380,300 |
| 2024/11/07 | 4,100 | 4,158 | 4,087 | 4,147 | +50 | +1.2% | 355,400 |
| 2024/11/06 | 4,100 | 4,161 | 4,091 | 4,097 | +3 | +0.1% | 319,400 |
51～
100
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 350,400円 | +7.9% | +8.9% | 3.54% | 7.50倍 | 1.00倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 193,900円 | +5.0% | +1.5% | 0.00% | 16.65倍 | 4.43倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 住友ファーマ | 62,100円 | +21.1% | - | 0.00% | 15.42倍 | 2.16倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| 科研薬 | 444,100円 | +22.8% | +113.0% | 4.28% | 12.34倍 | 1.10倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 371,500円 | +14.5% | -2.3% | 2.42% | 13.59倍 | 0.72倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム
